Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
NCT06000423Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in Menstrual Disorder, sponsored by Oregon Health & Science University. Started Jan 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Menstrual Disorder
Beyond the preview
Go deeper on NCT06000423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06000423.